Charcot-Marie-Tooth disease type 2 caused by mutation in RAB7A is usually called CMT2B. It is a rare inherited nerve disease where damage mainly affects the long sensory and motor nerves in the legs and feet, leading to numbness, weakness, foot deformity, ulcers, and sometimes toe amputations. It is autosomal-dominant, meaning one changed copy of the RAB7A gene is enough to cause disease. RAB7A controls late endosome/lysosome transport, and the mutation disrupts growth-factor signalling and axon health, so nerves slowly degenerate. PMC+2PMC+2
Charcot-Marie-Tooth disease type 2 caused by mutation in the RAB7A gene is usually called Charcot-Marie-Tooth disease type 2B (CMT2B). It is a rare, inherited nerve disease that mainly affects the long nerves in the legs and arms. These nerves slowly become damaged, so the muscles and skin at the ends of the limbs (feet, toes, hands, fingers) lose strength and feeling over many years.National Organization for Rare Disorders+1
CMT2B is an axonal form of Charcot-Marie-Tooth disease, which means the main problem is in the long cable part of the nerve cell (the axon), not mainly in the myelin covering. Because the axons are sick, signals for movement and feeling travel poorly, and this leads to weakness, numbness, and foot problems.ScienceDirect+1
The RAB7A gene gives instructions to make a small protein called Rab7, which works like a traffic controller inside the cell. It controls how late endosomes and lysosomes move and fuse, and helps recycle or break down many important cell proteins. When RAB7A has a harmful mutation, this traffic system does not work well in nerve cells, so waste builds up, growth signals change, and the axon slowly degenerates.PMC+2Springer Link+2
People with CMT2B often have very marked loss of sensation, ulcers on the feet, infections, and sometimes toe amputations because they do not feel pain well. Weakness and wasting of foot and lower leg muscles can also appear and cause difficulty walking and ankle instability. The disease usually begins in youth or adulthood and progresses slowly over time.PMC+2PubMed+2
Other names
CMT2B due to RAB7A mutations has several other names used in books and research papers. These different terms all describe the same or very closely related condition:PMC+1
Charcot-Marie-Tooth disease type 2B (CMT2B) – the most common short name.
Charcot-Marie-Tooth disease, axonal, type 2B – to show it is an axonal neuropathy.
Hereditary motor and sensory neuropathy type 2B (HMSN IIB) – an older name that highlights both movement and sensory nerve problems.
RAB7A-related Charcot-Marie-Tooth neuropathy – a gene-based name.
Ulcero-mutilating neuropathy due to RAB7A mutation – this stresses the severe foot ulcers and tissue damage seen in many patients.
These names may appear in medical records, genetic test reports, or research articles, but they all point to the same RAB7A-linked CMT2 form.PMC+1
Types and subtypes
Doctors group Charcot-Marie-Tooth disease mainly into demyelinating (CMT1) and axonal (CMT2) forms based on nerve conduction speed. CMT2 has many gene-based subtypes, and the subtype caused by RAB7A mutations is called CMT2B.ScienceDirect+1
Even inside CMT2B, there can be different clinical patterns (phenotypes). Researchers have described several useful “types” of presentation:PMC+2MDPI+2
Classical ulceromutilating CMT2B – strong loss of pain and temperature sensation, severe foot ulcers, infections, and risk of toe amputations, with moderate weakness.
Sensory-predominant CMT2B – loss of feeling is much stronger than muscle weakness; patients may mainly complain of numbness, burning, and ulcers.
Motor-predominant CMT2B – in some families, new RAB7A mutations cause more leg weakness and foot drop, with less ulceration, looking more like typical axonal CMT.
Early-onset form – symptoms begin in childhood or teenage years, with long-term risk of joint deformities and severe disability if not well managed.
Late-onset form – symptoms first appear in mid- or late adulthood, often with slower progression and less deformity.
CMT2B with autonomic features – some people also show abnormal sweating, skin color changes, or blood pressure changes, suggesting mild autonomic nerve involvement.
These patterns do not change the basic cause (RAB7A mutation) but help doctors describe and follow the disease course in different patients.PubMed+2European Reference Network+2
Causes and contributing factors
For CMT2B, there is one main cause: a harmful mutation in the RAB7A gene. All other “causes” listed below are better thought of as mechanisms or factors that influence how the disease behaves, not separate independent causes.
Autosomal dominant RAB7A gene mutation
The key cause is a missense mutation in one copy of the RAB7A gene, usually inherited in an autosomal dominant pattern, meaning one changed copy is enough to cause disease. The mutation changes one amino acid in the Rab7 protein and alters its activity in nerve cells.PMC+2PLOS+2Gain-of-function effect in Rab7 protein
Many CMT2B mutations cause the Rab7 protein to become abnormally active or “gain function,” which changes how endosomes and lysosomes move and fuse inside the cell. This over-active protein disrupts normal recycling of receptors and membrane proteins and stresses the neuron.PMC+2JBC+2Abnormal late endocytic pathway
Rab7 is a key controller of late endosome and lysosome trafficking, so its mutation leads to problems in how these compartments mature, move, and fuse. In neurons, this disturbed pathway harms the long axons, because they depend on healthy transport and waste clearance over very long distances.Springer Link+1Disrupted neurotrophin signaling
Rab7 is important for carrying growth signals such as nerve growth factor (NGF) inside neurons. Mutant Rab7 alters this signaling, so nerve cells may not receive proper survival and growth messages, leading to slow axon degeneration.PLOS+2Journal of Neuroscience+2Mitochondrial dysfunction and altered energy use
Recent work shows that Rab7 mutations can change mitochondrial shape and function, leading to reduced energy supply and increased oxidative stress inside peripheral nerves. Since axons are long and energy-hungry, this mitochondrial stress makes them more likely to degenerate.Nature+1Axonal transport problems
Nerve cells rely on microtubule-based transport to move cargo up and down the axon. Mutant Rab7 affects vesicle movement and may disturb the transport of mitochondria, receptors, and enzymes, which slowly starves the distal axon of needed materials.ScienceDirect+1Impaired lysosomal degradation
When Rab7 function is changed, proteins and organelles that should be broken down in lysosomes may accumulate. This buildup of “cellular garbage” can be toxic to neurons over years and contributes to chronic axonal damage.ScienceDirect+1Axonal length vulnerability
The longest nerves to the feet and toes are most vulnerable to small problems in cell transport and energy. Because of their length, even mild Rab7 dysfunction first shows up as distal sensory loss and ulcers in the feet.ScienceDirect+1Genetic background (modifier genes)
Other genes in the same person can modify how severe CMT2B becomes. For example, genes that affect myelin health, mitochondrial repair, or inflammation may make symptoms worse or milder, even when the RAB7A mutation is the same.balkanmedicaljournal.org+1De novo RAB7A mutation
In some cases, the RAB7A mutation appears for the first time in a child, without being present in either parent. This “de novo” event is rare, but when it happens, it can cause CMT2B in a previously unaffected family.MalaCards+1Chronic foot trauma and pressure
People with CMT2B have numb feet and weak muscles, so they may not feel small injuries or pressure points in shoes. Repeated minor trauma can worsen ulcers and infections and lead to tissue loss, adding to disability. This is not the root cause, but it worsens nerve-related damage.PMC+1Infections in the feet and toes
Loss of protective sensation means cuts and blisters can get badly infected before the person notices. Infections can cause more tissue damage, gangrene, and sometimes amputations, and they strongly shape how severe the disease looks clinically.PMC+1Co-existing diabetes or metabolic disease
If a person with CMT2B also has diabetes or metabolic syndrome, the sugar-related nerve damage and blood vessel disease add to the inherited neuropathy. This combined injury can cause faster progression of numbness, pain, and ulcers.Europe PMC+1Nutritional deficiencies (e.g., vitamin B12)
Lack of key nutrients like vitamin B12 can cause additional nerve damage on top of CMT2B. This is not a primary cause, but if present, it can worsen weakness and sensory loss and should be corrected.diposit.ub.edu+1Alcohol-related nerve toxicity
Heavy alcohol use can also cause peripheral neuropathy. In a person with CMT2B, alcohol-related nerve damage acts as an extra injury, so symptoms progress more quickly and function declines faster.diposit.ub.edu+1Autoimmune or inflammatory neuropathy on top of CMT2B
Rarely, a separate autoimmune attack on nerves (such as chronic inflammatory demyelinating polyneuropathy) can occur in a person who already has CMT2B, making weakness and numbness suddenly worse. In these cases, treatment of the immune disease is important.diposit.ub.edu+1Poor footwear and foot care
Badly fitting shoes, walking barefoot on rough ground, or not checking the feet daily can lead to more ulcers and deformity in CMT2B. Good foot care does not cure the disease, but poor care strongly increases visible damage.Mayo Clinic+1Smoking and vascular disease
Smoking damages small blood vessels and reduces blood flow to nerves and skin. In CMT2B, this extra vascular problem may slow healing of ulcers and make nerve damage worse over time.Europe PMC+1Obesity and reduced activity
Extra body weight and low physical activity put more pressure on weak feet and can speed loss of mobility in CMT2B. Although they do not cause the gene problem, they are important lifestyle factors that influence outcome.Europe PMC+1Age-related axonal loss
As everyone ages, some nerve fibers are naturally lost. In CMT2B, the axons already start out weaker, so age-related loss has a bigger impact, causing worsening balance, falls, and disability in older adults.Europe PMC+1
Symptoms
Symptoms in RAB7A-related CMT2B mainly affect the feet and legs, and later the hands. They usually begin slowly and worsen over many years.National Organization for Rare Disorders+1
Distal sensory loss in the feet
The most important symptom is loss of feeling, especially pain and temperature, in the toes and soles. People may not feel sharp objects, hot surfaces, or blisters, which leads to injuries they do not notice.PMC+1Foot ulcers and non-healing wounds
Because of numbness, repeated pressure and small cuts can grow into deep ulcers on the feet and ankles. These ulcers may heal poorly, become infected, and sometimes require surgery or amputation.PMC+1Infections and tissue loss (ulcero-mutilating features)
Severe, long-lasting ulcers can lead to bone infection and tissue destruction. Some patients lose toes or parts of the foot, which is why this form is called “ulcero-mutilating neuropathy.”PMC+1Distal muscle weakness in legs
Over time, the nerves that supply the muscles of the feet and lower legs also become damaged, causing weakness. People may find it hard to stand on tiptoe, run, or climb stairs, and may notice their ankles rolling outwards.American Academy of Neurology+1Muscle wasting (atrophy)
Chronic weakness leads to thinning of the muscles in the calves, feet, and later hands. The legs may look like an “inverted champagne bottle,” with thin lower legs and relatively normal thighs.American Academy of Neurology+1Foot deformities (pes cavus, hammertoes)
Imbalance between weak and stronger muscles in the foot causes high arches (pes cavus), clawed toes, and other deformities. These deformities change weight-bearing areas and further increase risk of ulcers.National Organization for Rare Disorders+1Foot drop and tripping
Damage to the peroneal nerve and front leg muscles leads to difficulty lifting the front of the foot. This “foot drop” makes people trip easily, especially on uneven ground or stairs.Europe PMC+1Impaired balance and unsteady gait
Loss of joint position sense and weakness combine to cause a wide-based, unsteady walk. People may need to watch their feet while walking, hold onto railings, or use a cane or walker in later stages.Europe PMC+1Neuropathic pain or burning
Some patients feel burning, tingling, or shooting pains in the feet and legs, even though they also have numbness. This “neuropathic pain” comes from damaged nerves sending abnormal signals.Europe PMC+1Reduced or absent tendon reflexes
When the doctor tests ankle or knee reflexes with a hammer, the responses are often reduced or missing. This reflects damage to the reflex arc in the peripheral nerves.Europe PMC+1Hand sensory loss and weakness
In many people, numbness and weakness later spread to the hands and fingers. This makes it hard to do fine tasks such as buttoning clothes, writing, or using tools.National Organization for Rare Disorders+1Autonomic symptoms in some patients
A few reports describe abnormal sweating, color changes in the skin, or mild blood pressure swings, suggesting small autonomic nerve involvement, although this is not present in all patients.PubMed+1Fatigue and reduced stamina
Because movement takes more effort with weak muscles and poor balance, people often feel tired after walking short distances and may need frequent rests.Europe PMC+1Psychological impact (anxiety, low mood)
Chronic pain, visible deformities, risk of ulcers, and fear of falls can cause anxiety and depression. Support, counseling, and realistic information about the disease course are important.Mayo Clinic+1Breathing or swallowing problems (rare, advanced)
In very advanced or severe forms, especially with long disease duration, weakness can involve trunk or bulbar muscles, leading to mild breathing or swallowing difficulties, though this is not typical for most CMT2B patients.Europe PMC+1
Diagnostic tests
Diagnosis of RAB7A-related CMT2B is based on a mix of clinical examination, electrodiagnostic tests, genetic testing, and sometimes pathological and imaging studies. These tests help to confirm that the neuropathy is axonal, inherited, and due to a RAB7A mutation, and to rule out other causes.diposit.ub.edu+2PMC+2
Physical examination tests
1. Detailed neurological history and examination
The doctor asks about age at onset, family history, progression of weakness and numbness, and presence of ulcers and amputations. A full neurological exam checks strength, sensation, reflexes, and coordination to see the typical pattern of length-dependent sensorimotor neuropathy.Europe PMC+1
2. Muscle strength grading (MRC scale)
Muscle power in ankles, toes, knees, and hands is tested and scored using the Medical Research Council (MRC) scale from 0 to 5. Distal muscles are usually weaker than proximal ones, supporting the diagnosis of length-dependent axonal neuropathy.Europe PMC+1
3. Sensory examination for touch, pain, temperature, vibration
Light touch, pinprick, warm and cold stimuli, and vibration (using a tuning fork) are tested on feet and hands. In CMT2B, there is often severe loss of pain and temperature sensation in the feet, with variable loss of other sensory modes.PMC+1
4. Deep tendon reflex testing
Knee and ankle reflexes are checked with a reflex hammer. In CMT2B and other axonal CMT forms, these reflexes are usually decreased or absent in the legs and sometimes later in the arms, which supports a peripheral neuropathy.Europe PMC+1
Manual and bedside functional tests
5. Gait observation and timed walking tests
The clinician watches the patient walk, turn, and sometimes do timed walking (for example, 10-meter walk). Foot drop, steppage gait, and frequent tripping suggest distal weakness, and long-term follow-up of gait helps judge progression and treatment needs.Europe PMC+1
6. Romberg and balance tests
Standing with feet together, first with eyes open and then closed, checks joint position sense and balance. People with CMT2B often sway or fall when they close their eyes because they rely on vision to compensate for poor sensation in their feet.Europe PMC+1
7. Foot and hand deformity assessment
The doctor inspects the shape of the feet and hands, looking for high arches, hammertoes, clawed fingers, and calluses. Manual movement of joints assesses stiffness and flexibility and helps plan orthotic and surgical treatment when needed.National Organization for Rare Disorders+1
8. Vibration and joint position testing with tuning fork and joint movement
Using a tuning fork on bony points and moving toes or fingers up and down while the patient identifies the direction assesses large-fiber sensory function. Marked loss of vibration and position sense in the toes is a typical sign of advanced axonal neuropathy.diposit.ub.edu+1
Lab and pathological tests
9. Basic blood tests to rule out other neuropathy causes
Blood tests such as full blood count, fasting glucose, HbA1c, vitamin B12, folate, thyroid function, and kidney and liver tests are done to exclude other common causes of neuropathy, like diabetes or vitamin deficiency, which can coexist with CMT2B.diposit.ub.edu+1
10. Nerve biopsy (usually sural nerve)
In uncertain cases or research settings, a small cut of a sensory nerve (often the sural nerve at the ankle) is taken and examined under a microscope. In CMT2 forms, the biopsy shows chronic axonal loss and regeneration, helping to confirm an axonal inherited neuropathy, although today biopsy is less common.ScienceDirect+1
11. Skin biopsy for small fiber assessment
A tiny skin sample can be used to count nerve fibers in the skin. This test helps measure small fiber loss and clarify sensory neuropathy, especially when nerve conduction tests are normal or borderline.diposit.ub.edu+1
12. Targeted RAB7A genetic test
If the clinical picture fits CMT2B, a blood sample can be sent for direct sequencing of the RAB7A gene. Finding a known disease-causing mutation confirms the diagnosis, guides family screening, and avoids more invasive tests.MalaCards+2South Carolina Blues+2
13. Extended CMT gene panel testing
Often, doctors order a broader panel that includes many CMT genes (such as MFN2, GJB1, MPZ, and RAB7A) rather than a single-gene test. This improves the chance of finding the correct gene, especially when the phenotype is not classic.PMC+1
14. Family genetic testing and counseling
Once a RAB7A mutation is found in one person, testing close family members helps identify who is at risk. Genetic counseling explains inheritance, family planning options, and the meaning of the results in simple language.PMC+1
Electrodiagnostic tests
15. Nerve conduction studies (NCS)
NCS use small electrical pulses along nerves in the arms and legs to measure speed and size of responses. In CMT2B, conduction speeds are usually near normal or only mildly slow, but the amplitude (size) of responses is reduced, which is typical for an axonal neuropathy.ScienceDirect+2diposit.ub.edu+2
16. Electromyography (EMG)
A fine needle electrode is placed in muscles to record electrical activity at rest and during contraction. EMG in CMT2B shows signs of long-standing denervation and reinnervation in distal muscles, supporting axonal motor involvement.diposit.ub.edu+1
17. Quantitative sensory or autonomic testing (optional)
Special tests can measure thresholds for feeling vibration, temperature, or pain, and can also study sweating or heart rate responses. These help describe the extent of sensory and autonomic involvement in complex cases or research studies.diposit.ub.edu+1
Imaging tests
18. X-rays of feet and ankles
Plain X-rays show bone structure, joint alignment, deformities such as high arches and hammertoes, and bone damage from chronic ulcers. This information helps orthopedic and foot surgeons plan braces or corrective surgery.Mayo Clinic+1
19. MRI of spine and nerve roots (to rule out other causes)
MRI scanning of the spine and nerve roots can rule out structural problems such as spinal cord compression or root lesions that might mimic neuropathy. Normal imaging supports the diagnosis of a primary peripheral neuropathy like CMT2B.diposit.ub.edu+1
20. Ultrasound or MRI of peripheral nerves
High-resolution ultrasound or MRI can sometimes show thinning or mild enlargement of peripheral nerves and help distinguish inherited neuropathies from inflammatory forms. It is mainly a research and specialized clinical tool but can add useful structural information in selected patients.diposit.ub.edu+1
Non-pharmacological treatments
1. Individualized physical therapy and stretching
A regular physiotherapy program is the main non-drug treatment for CMT2B. It usually includes stretching tight calf and hamstring muscles, gentle range-of-motion exercises for ankles and toes, and strengthening of remaining muscles. This can slow contractures, improve walking, and decrease falls. Evidence from CMT trials shows strength and endurance training can improve function and daily activities when designed and monitored by specialists. Wiley Online Library+4PMC+4Physiopedia+4
2. Gait and balance training
Therapists often add specific balance tasks, treadmill work, or virtual-reality and robotic devices to train safe walking. People practise stepping over obstacles, turning, and dual-task walking (walking while talking), which are situations that commonly cause falls. Recent reviews of gait-focused therapy in CMT show improvements in walking speed, endurance, and confidence when programs are progressive and continued over time. MDPI+2Journal of Health and Allied Sciences NU+2
3. Strengthening of proximal muscles
In CMT2B, weakness often begins in the feet but can move up to lower legs and hands. Strengthening hips, thighs, and core muscles helps compensate for weak distal muscles and improves posture. Progressive resistance training, using bands or light weights, preserved ankle dorsiflexion strength in children with CMT in clinical trials, suggesting it is safe when supervised and not excessively fatiguing. ScienceDirect+1
4. Ankle-foot orthoses (AFOs)
Custom AFOs or dynamic carbon-fiber braces support weak ankles and lift the toes to prevent tripping (foot drop). Orthotic studies in CMT show that the right brace can improve stability, reduce energy cost of walking, and delay fixed deformity. Bracing should be regularly reviewed, because the shape of the foot and the level of weakness change over time. Charcot-Marie-Tooth Association+3Charcot-Marie-Tooth Association+3Physiopedia+3
5. Custom footwear and insoles
People with CMT2B often have high arches, claw toes, and pressure points that lead to calluses and ulcers. Special shoes with extra depth, rocker soles, and soft insoles spread pressure more evenly and protect skin. Podiatry and CMT organizations stress proper footwear as a core measure to prevent ulcers and amputations, especially in ulceromutilating types like CMT2B. CMT Research Foundation+3Mayo Clinic+3Charcot-Marie-Tooth Association+3
6. Hand therapy and occupational therapy
Occupational therapists teach hand-strengthening exercises, joint-protection techniques, and can provide splints for weak wrists or fingers. They also suggest adaptive tools such as built-up pens, zipper pulls, or modified keyboards to keep school, work, and self-care tasks manageable. Rehab reviews in CMT emphasize that early occupational therapy helps maintain independence and reduces frustration and fatigue. PMC+2PMC+2
7. Assistive devices for mobility
Canes, trekking poles, walkers, and later wheelchairs may be needed to prevent falls and allow safe participation in daily life. Using devices early is not a failure but a way to conserve energy and avoid fractures or head injuries. Guidelines for CMT management highlight assessment of walking aids as disease progresses. Mayo Clinic+2ScienceDirect+2
8. Structured foot-care and ulcer prevention
Because CMT2B causes prominent sensory loss, injuries and ulcers on the feet may go unnoticed. Daily inspection of skin, careful nail cutting, immediate treatment of small wounds, and regular podiatry visits are vital. Patient organizations warn that poorly treated ulcers can become infected and lead to toe or foot amputations in this subtype. Cleveland Clinic+3PMC+3National Organization for Rare Disorders+3
9. Wound care and off-loading
When ulcers appear, non-pharmacological management includes pressure off-loading with special boots or casts, frequent dressing changes, and sometimes negative-pressure therapy. These methods reduce mechanical stress, improve blood supply, and support healing while antibiotics treat infection if present. Foot-care sources for CMT and diabetic neuropathy emphasize off-loading as key to healing deep ulcers. Charcot-Marie-Tooth Association+2Cleveland Clinic+2
10. Pain psychology, CBT, and coping skills
Chronic neuropathic pain can cause anxiety, low mood, and sleep problems. Cognitive-behavioural therapy (CBT), mindfulness, and pain-education programs help people reframe pain, improve sleep, and reduce catastrophizing. Neuropathy guidelines recommend psychological approaches as part of comprehensive pain care, especially in young people who may feel overwhelmed by a genetic diagnosis. PMC+2nhs.uk+2
11. Energy-conservation and fatigue management
Therapists teach pacing, activity scheduling, use of rest breaks, and planning routes to reduce walking distance. These strategies help people manage fatigue, which is common in neuromuscular diseases. Rehabilitation reviews in CMT note that energy management can improve participation without increasing weakness. PMC+2MDPI+2
12. Falls-prevention training and home safety
Assessment of home hazards, adding grab bars, improving lighting, and avoiding loose rugs can significantly reduce falls. Education about safe transfers, stair use, and footwear also lowers risk. CMT resources repeatedly highlight falls and fractures as major avoidable complications of distal weakness and sensory loss. Mayo Clinic+2Charcot-Marie-Tooth Association+2
13. Respiratory and sleep assessment (if needed)
Most people with CMT2B do not have major breathing problems, but those with scoliosis or very weak trunk muscles may develop sleep-disordered breathing. Periodic sleep studies and pulmonary function tests allow early use of non-invasive ventilation when needed. Peripheral neuropathy and neuromuscular guidelines recommend screening when symptoms such as morning headaches, loud snoring, or daytime sleepiness appear. PMC+1
14. Vocational and school support
Career counselling, workplace adaptations (ergonomic chairs, speech-to-text software, flexible schedules) and school accommodations help individuals keep studying or working. Rehab management papers for CMT stress assistance with school and job planning as a core part of long-term care. PMC+2PMC+2
15. Genetic counselling for person and family
Because CMT2B is autosomal-dominant, a person has a 50% chance of passing the mutation to each child. Genetic counselling explains inheritance, options for testing, and possible future reproductive choices. Rare-disease resources describe counselling as essential for informed family planning and reducing guilt or blame. National Organization for Rare Disorders+2CMT Research Foundation+2
16. Patient support groups and education
Charcot-Marie-Tooth associations and online communities provide education, peer support, and information on research and clinical trials. Studies in chronic neurological disease show that support groups can reduce isolation and improve coping and self-management skills. Mayo Clinic+2Muscular Dystrophy Association+2
17. Weight management and aerobic exercise
Low-impact activities such as cycling, swimming, and walking in water help maintain cardiovascular health without excessive stress on weak ankles. Keeping body weight in a healthy range reduces load on feet and can ease pain and fatigue. Systematic reviews show aerobic training in CMT can improve fitness and quality of life when tailored to ability. PubMed+2Wiley Online Library+2
18. Avoidance of neurotoxic drugs and toxins
Some chemotherapy agents, excess alcohol, and certain antibiotics can worsen peripheral nerve damage. Lists of “CMT-toxic” drugs are published by CMT foundations, and guidelines advise careful review of all medicines with a neurologist or pharmacist before starting them. PMC+2Mayo Clinic+2
19. Orthopedic monitoring of spine and joints
Regular review by orthopedic specialists detects scoliosis, hip problems, or severe contractures early. Bracing or early surgery may prevent progression of deformities. Orthopedic literature in CMT underlines the importance of timely interventions before joints become rigid. PubMed+2www.elsevier.com+2
20. Participation in clinical research
Although no approved disease-modifying therapy exists yet, trials are running for gene-based treatments, neuroprotective agents, and combination drugs in CMT. Taking part in ethically approved research may give access to new therapies and helps scientists understand CMT2B biology better. MDPI+2ResearchGate+2
Drug treatments
Important note: No medicine is currently approved specifically for “CMT2B”. The drugs below are used to treat symptoms such as neuropathic pain or ulcers, based on evidence in other neuropathies. Always follow your own doctor’s advice; do not change medicines yourself.
1. Pregabalin (Lyrica – anticonvulsant / neuropathic pain drug)
Pregabalin is an anti-seizure medicine that also calms overactive pain nerves. The FDA has approved it for several neuropathic pains, including diabetic peripheral neuropathy and post-herpetic neuralgia. Typical adult doses for neuropathic pain are 150–600 mg per day, divided into two or three doses, adjusted by the doctor. Common side effects include dizziness, sleepiness, weight gain, and leg swelling. FDA Access Data+2FDA Access Data+2
2. Duloxetine (Cymbalta – serotonin-noradrenaline reuptake inhibitor)
Duloxetine is an antidepressant that also treats nerve pain by increasing serotonin and noradrenaline in pain pathways. The FDA label includes management of diabetic peripheral neuropathic pain and fibromyalgia. For neuropathic pain, 60 mg once daily is usually recommended, sometimes starting at 30 mg for a week. Nausea, sleepiness, dry mouth, and sweating are frequent side effects, and it must be used carefully in people with liver disease. FDA Access Data+2FDA Access Data+2
3. Gabapentin (Neurontin – anticonvulsant)
Gabapentin reduces abnormal electrical activity in damaged nerves. It is FDA-approved for post-herpetic neuralgia and seizures and is widely used off-label for many neuropathic pains. Neuropathic pain doses often range from 900–3600 mg per day in divided doses, adjusted slowly. Side effects include dizziness, drowsiness, and swelling. In CMT, gabapentin can help burning or shooting pain but does not change disease progression. FDA Access Data+2FDA Access Data+2
4. Tapentadol extended-release (Nucynta ER – opioid analgesic with noradrenaline reuptake inhibition)
Tapentadol ER is a strong opioid-like painkiller that also blocks noradrenaline reuptake, helping to reduce neuropathic pain. FDA indications include severe and persistent neuropathic pain associated with diabetic peripheral neuropathy that requires long-term opioid therapy. Because of high risks of addiction, overdose, and serious side effects, it is reserved for severe cases when safer options fail. Massachusetts Government+3FDA Access Data+3FDA Access Data+3
5. Capsaicin 8% patch (Qutenza – topical analgesic)
Qutenza is a high-dose capsaicin skin patch applied in a clinic to painful areas of the feet or legs. Capsaicin temporarily “defunctionalizes” pain-signalling nerve endings, leading to reduced burning pain for months in some people. The FDA label covers neuropathic pain associated with post-herpetic neuralgia and diabetic peripheral neuropathy of the feet in adults. Side effects include local burning, redness, and temporary increased pain right after application. FDA Access Data+2FDA Access Data+2
6. Lidocaine 5% patch (Lidoderm – topical local anaesthetic)
Lidocaine patches deliver a local anaesthetic through the skin and are approved for pain after shingles (post-herpetic neuralgia). They stabilise nerve membranes and reduce abnormal firing in superficial sensory fibres. Patches are usually applied to intact skin for up to 12 hours per day. In neuropathy, they may help localized burning areas without causing whole-body side effects, although skin irritation and numbness are possible. FDA Access Data+2MedlinePlus+2
7. Tricyclic antidepressants (e.g., amitriptyline)
Amitriptyline is an older antidepressant with strong pain-modulating effects; it blocks reuptake of serotonin and noradrenaline and also acts on sodium channels. While FDA labels focus on depression and anxiety combinations, tricyclics are widely recommended in neuropathy guidelines as first-line agents, usually taken at low doses at night (for example, 10–75 mg) to improve pain and sleep. Dry mouth, constipation, and drowsiness are common side effects, and overdose can be dangerous. FDA Access Data+2FDA Access Data+2
8. Serotonin-noradrenaline reuptake inhibitors other than duloxetine (e.g., venlafaxine)
Venlafaxine has a similar mechanism to duloxetine, increasing descending inhibition of pain. Although its FDA label centres on depression and anxiety disorders, clinical studies suggest benefit for some neuropathic pains. Doctors sometimes use it when duloxetine is not tolerated, titrating doses carefully to avoid blood-pressure increases and withdrawal effects. nhs.uk+2PMC+2
9. Simple analgesics (paracetamol / acetaminophen)
Acetaminophen does not treat neuropathic pain directly but can help with background musculoskeletal discomfort and mild joint pain related to altered gait. It acts mainly in the central nervous system, lowering prostaglandin activity. When used within recommended daily limits and under medical advice, it is generally safe, but overdose can cause severe liver damage. nhs.uk+2Mayo Clinic+2
10. Non-steroidal anti-inflammatory drugs (NSAIDs – e.g., ibuprofen, naproxen)
NSAIDs reduce inflammation and pain in joints, tendons, and muscles stressed by altered walking patterns. They work by blocking cyclo-oxygenase enzymes and prostaglandin production. They are not specific treatments for neuropathic pain and should be used short-term, as long-term use can damage the stomach, kidneys, and cardiovascular system. nhs.uk+2Mayo Clinic+2
11. Tramadol (weak opioid with monoamine effects)
Tramadol acts as a weak opioid and also inhibits serotonin and noradrenaline reuptake, so it can help mixed nociceptive and neuropathic pain. It is sometimes used as a step-up therapy when first-line neuropathic pain medications fail. It carries risks of dependence, nausea, dizziness, and, rarely, seizures or serotonin syndrome when combined with other serotonergic drugs. nhs.uk+2FDA Access Data+2
12. Topical diclofenac gel
Diclofenac gel provides local anti-inflammatory effects for joint and soft-tissue pain related to altered posture in CMT2B. Applying it over painful ankles or knees may reduce swelling and discomfort with fewer whole-body adverse effects than oral NSAIDs, though skin irritation can occur. nhs.uk+1
13. Antibiotics for infected ulcers (e.g., amoxicillin-clavulanate, clindamycin – chosen by culture)
When foot ulcers become infected, systemic antibiotics are required to control bacteria and prevent bone infection or sepsis. The choice and dose depend on local guidelines, wound cultures, and kidney function. Antibiotics do not treat the neuropathy itself, but they are life-saving when serious infections occur in ulceromutilating CMT2B. ajmcrr.com+3Mayo Clinic+3Charcot-Marie-Tooth Association+3
14. Antidepressants and anxiolytics for mood and adjustment
Living with a progressive genetic neuropathy may lead to depression or anxiety. Selective serotonin reuptake inhibitors (SSRIs) or other antidepressants, prescribed under supervision, can improve mood and coping, which indirectly reduces pain intensity and improves quality of life. PMC+2Mayo Clinic+2
15. Sleep medications (used cautiously)
When neuropathic pain and cramps disturb sleep, doctors may occasionally prescribe short-term sleep aids. Good sleep helps pain processing and daytime function. However, sedative drugs can increase fall risk and respiratory problems, so non-drug sleep strategies are preferred whenever possible. Mayo Clinic+2PMC+2
16. Muscle relaxants for cramps (e.g., baclofen – oral)
Oral baclofen is a GABA-B receptor agonist that reduces spasticity and cramps in some neurological diseases. In CMT, it may help painful muscle spasms but does not affect the underlying neuropathy. Drowsiness and weakness are common side effects, so dose titration must be slow and supervised. PMC+2PMC+2
17. Vitamin B12 replacement (if deficient)
Vitamin B12 deficiency itself causes neuropathy and can worsen symptoms in someone with CMT2B. When deficiency is found, high-dose tablets or injections can improve nerve function and pain. B12 promotes myelin formation and axon repair. Treatment regimens often start with frequent injections then move to maintenance doses. Cleveland Clinic+2PubMed+2
18. Alpha-lipoic acid (prescription strength where available)
Alpha-lipoic acid is an antioxidant that may reduce oxidative stress in peripheral nerves. Clinical studies in diabetic neuropathy using doses around 600 mg/day have shown modest improvements in symptoms, although recent reviews suggest the effect may be small. It is not a proven treatment for CMT2B but may be considered as an adjunct under medical guidance. Cureus+3PMC+3Diabetes Journals+3
19. Acetyl-L-carnitine (ALC)
ALC supports mitochondrial energy production and has shown neuroprotective and analgesic effects in various peripheral neuropathies. Meta-analyses suggest moderate pain reduction and improved nerve tests at doses typically around 1–3 g/day, though it is not disease-specific for CMT. Side effects are usually mild (nausea, restlessness), but long-term safety data are still limited. ClinicalTrials.gov+3PMC+3PLOS+3
20. Topical capsaicin creams and gels (low-dose, over-the-counter in some countries)
Low-dose capsaicin creams are weaker versions of the 8% patch and can be applied at home for small painful areas. They repeatedly activate and then desensitize TRPV1 receptors on pain fibres, leading to gradual reduction of burning or tingling sensations. Irritation and burning at the start are common, so they must be used exactly as directed and kept away from eyes and broken skin. FDA Access Data+2FDA Access Data+2
Dietary molecular supplements
1. Alpha-lipoic acid (ALA)
ALA is an antioxidant cofactor in mitochondrial enzymes. In diabetic neuropathy studies, oral ALA (often 600 mg/day) has been shown to improve some neuropathic symptoms, probably by reducing oxidative stress and improving microcirculation to nerves. Recent high-quality reviews suggest the benefits are modest, but it may be useful as an add-on, not a replacement for standard care. Cochrane Library+3PMC+3Diabetes Journals+3
2. Acetyl-L-carnitine
ALC plays a role in transporting fatty acids into mitochondria for energy production. Trials in painful peripheral neuropathy report moderate pain reductions and improved nerve conduction, possibly through neurotrophic and membrane-stabilising effects. Typical study doses range from 1 to 3 g/day, divided, under medical supervision. ClinicalTrials.gov+3PMC+3PLOS+3
3. Omega-3 polyunsaturated fatty acids (fish-oil EPA/DHA)
Omega-3 fats help maintain healthy nerve membranes and may have anti-inflammatory and pro-regenerative effects. Animal studies and small human trials suggest possible improvements in nerve regeneration and function after injury, although a recent Cochrane review found uncertain benefit in diabetic neuropathy. Still, a diet rich in oily fish or supervised supplementation may support overall nerve health. Omegor.com+3PMC+3Frontiers+3
4. Vitamin B12 (methylcobalamin or hydroxocobalamin)
Even when levels are in the low-normal range, some clinicians use high-dose B12 to support myelin repair and nerve regeneration. Experimental and clinical work suggests B12 can decrease ectopic nerve firing and promote remyelination in neuropathic pain. Oral tablets or injections are chosen depending on absorption. Verywell Health+3Cleveland Clinic+3PubMed+3
5. B-complex vitamins (B1, B6, B9)
Thiamine (B1), pyridoxine (B6), and folate (B9) are essential for nerve metabolism and neurotransmitter synthesis. Deficiencies can cause or worsen neuropathy, so correcting them is important. However, very high B6 doses can themselves cause neuropathy, so balanced B-complex formulations and medical monitoring are recommended. nhs.uk+2Verywell Health+2
6. Vitamin D
Vitamin D receptors are present in nerve tissue, and low vitamin D is common in people with chronic illness and reduced outdoor activity. While strong proof that vitamin D improves neuropathy is lacking, maintaining normal levels supports bone health, muscle strength, and immune function, all important in CMT2B. nhs.uk+2Mayo Clinic+2
7. Coenzyme Q10
CoQ10 is involved in mitochondrial electron transport and acts as an antioxidant. Small studies in mitochondrial and other neuromuscular disorders suggest it may improve fatigue and some functional measures, though evidence in CMT is very limited. It is usually considered an adjunctive option in people with suspected mitochondrial stress. Verywell Health+2ScienceDirect+2
8. Magnesium
Magnesium participates in nerve conduction and muscle relaxation. Some people with neuropathic pain and cramps report benefit from correcting low magnesium levels, which can occur with certain medications or diets. However, evidence is limited, and high doses can cause diarrhoea or, rarely, heart rhythm problems in those with kidney disease. Verywell Health+2nhs.uk+2
9. Curcumin (from turmeric)
Curcumin has anti-inflammatory and antioxidant properties and has been studied in various pain conditions. Experimental work suggests it may modulate inflammatory pathways and oxidative damage in nerves, but robust human data in neuropathy are still lacking. It should be seen as a supportive dietary component rather than a primary treatment. Verywell Health+2PMC+2
10. Resveratrol and other polyphenols
Polyphenols from grapes, berries, and other plants may protect nerves by reducing oxidative stress and improving mitochondrial function in experimental models. Human studies are small and preliminary, so these compounds are best obtained from a plant-rich diet rather than high-dose supplements unless a specialist advises otherwise. PMC+2ScienceDirect+2
Immunity-boosting, regenerative and stem-cell-related drugs
1. Mesenchymal stem cell (MSC) therapies (experimental)
MSC therapies using cells from bone marrow, umbilical cord, or other tissues are being researched for peripheral neuropathy. Animal studies and early human work in diabetic neuropathy suggest possible improvements in nerve conduction, blood flow, and pain through secretion of growth factors and immune-modulating molecules. However, no MSC therapy is yet proven or approved for CMT2B, and commercial clinics may overstate benefits. dvcstem.com+4ClinicalTrials.gov+4PMC+4
2. MSC-derived exosomes (research stage)
Exosomes are tiny vesicles released by stem cells that carry proteins, RNA, and lipids. Preclinical studies in neuropathic pain models show that MSC-derived exosomes can reduce inflammation, support axon regrowth, and promote new blood vessel formation. They are being explored as a cell-free regenerative therapy but remain experimental and not specifically studied in CMT2B yet. Frontiers+2PMC+2
3. PXT3003 (baclofen, naltrexone, sorbitol combination – for CMT1A, not CMT2B)
PXT3003 combines low doses of baclofen, naltrexone, and sorbitol to reduce expression of PMP22 in CMT1A, aiming to normalise myelin. Phase 3 trials in CMT1A have shown encouraging functional outcomes. Although it targets another gene (PMP22, not RAB7A), it illustrates how multi-drug combinations may one day modify CMT biology. It is not yet approved or studied in CMT2B. DrugBank+4PMC+4MDPI+4
4. Gene-therapy approaches to RAB7A (preclinical)
Laboratory studies show that RAB7A mutations disturb endosomal trafficking and nerve growth factor signalling in neurons and animal models. In theory, gene-replacement or gene-editing strategies (for example, viral vectors or CRISPR) could correct the mutant gene, but work in CMT2B is still at an early research stage, and no human trials are active yet. PLOS+3PMC+3eLife+3
5. Neurotrophic-factor–based therapies (experimental)
Some regenerative strategies aim to deliver nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), or related molecules to support axon survival. Because RAB7A mutations affect NGF-TrkA signalling, boosting or normalising this pathway might protect nerves, but so far these approaches remain mainly experimental and are not standard clinical care. PLOS+3PMC+3ScienceDirect+3
6. Immune-modulating agents in overlapping conditions
In rare situations, a person with CMT2B may also have an autoimmune neuropathy or autoimmune disease. In such cases, immune-modifying drugs (for example, steroids, IVIG, or biologics) may help the autoimmune process but do not treat the underlying RAB7A mutation. Their use must be guided strictly by specialist neurologists. PMC+2ScienceDirect+2
Surgeries
1. Cavovarus foot corrective surgery (osteotomy and tendon transfer)
Many people with CMT2B develop high-arched, inward-turning feet (cavovarus). Surgery may include plantar fascia release, first-metatarsal dorsiflexion osteotomy, calcaneal osteotomy, and tendon transfers to rebalance muscles. The aim is to correct deformity, improve foot alignment, relieve pain, and allow more stable walking. Studies report improved foot scores and function when surgery is timed before joints become rigid. ScienceDirect+3PubMed+3www.elsevier.com+3
2. Tendon transfer for foot drop
If ankle dorsiflexion is very weak, surgeons can transfer a stronger tendon (such as posterior tibial tendon) to the top of the foot. This allows active lifting of the foot during swing phase and can reduce need for braces. It is usually reserved for flexible deformities and carefully planned with physiotherapists and orthotists. www.elsevier.com+2ScienceDirect+2
3. Toe deformity correction (claw toes, hammertoes)
Surgery on toes (tendon lengthening, joint fusion, or soft-tissue balancing) may be done to relieve painful pressure points and make shoe-wear easier. The purpose is mainly to reduce pain and ulcer risk rather than to improve strength. Cleveland Clinic+3PubMed+3www.elsevier.com+3
4. Ulcer debridement and skin grafts
Deep or infected ulcers in CMT2B may require surgical cleaning (debridement) of dead tissue and sometimes skin grafts or flap coverage. Removing non-viable tissue helps control infection and allows healthier tissue to grow. This is often combined with antibiotics and off-loading devices. Charcot-Marie-Tooth Association+2Cleveland Clinic+2
5. Toe or partial foot amputation (last resort)
In severe, chronic ulcers with bone infection (osteomyelitis) that do not heal despite aggressive treatment, surgeons may need to amputate a toe or part of the foot. The goal is to remove infection, prevent life-threatening sepsis, and allow the person to mobilise on a stable, healed foot with custom footwear or prosthetics. ajmcrr.com+3PMC+3National Organization for Rare Disorders+3
Prevention and lifestyle tips
1. Daily foot checks – Look at soles, heels, and between toes every day using a mirror if needed; early treatment of blisters or cuts prevents ulcers. Charcot-Marie-Tooth Association+2Cleveland Clinic+2
2. Protective, properly fitting shoes – Wear cushioned, wide shoes with closed toes; avoid barefoot walking, especially outdoors, to reduce trauma. Charcot-Marie-Tooth Association+2Charcot-Marie-Tooth Association+2
3. Regular podiatry visits – Have nails, calluses, and pressure areas managed by professionals instead of self-cutting, which can cause wounds. Charcot-Marie-Tooth Association+2Cleveland Clinic+2
4. Don’t smoke or vape nicotine – Smoking damages blood vessels and reduces oxygen to nerves and skin, worsening neuropathy and delaying ulcer healing. nhs.uk+2ajmcrr.com+2
5. Keep a healthy weight and active lifestyle – Extra weight increases stress on weak ankles and feet and increases fatigue; gentle activity helps circulation and mood. PubMed+2Wiley Online Library+2
6. Avoid known neurotoxic medicines when possible – Always tell new doctors and dentists about CMT so they can choose drugs with lower neuropathy risk. PMC+2Mayo Clinic+2
7. Fall-proof your home – Good lighting, grab bars, handrails, and removing trip hazards reduce fractures and head injuries. Mayo Clinic+2Charcot-Marie-Tooth Association+2
8. Care for skin and nails – Keep feet moisturised but dry between toes; treat fungal infections quickly to prevent cracks and entry points for bacteria. Charcot-Marie-Tooth Association+2Cleveland Clinic+2
9. Stay up to date with vaccinations – Vaccines (for example, influenza, pneumonia as advised) can reduce infections that might require hospital stays and immobility. nhs.uk+2Mayo Clinic+2
10. Regular specialist follow-up – Seeing neuromuscular clinics, rehab teams, and orthopaedic teams regularly allows early adjustment of braces, therapies, and surgery plans. PMC+2ScienceDirect+2
When to see a doctor
You should see a doctor or neuromuscular specialist regularly for planned review, but urgent medical help is needed if you notice any of the following: rapidly worsening weakness, sudden loss of walking ability, new severe back pain with bladder or bowel problems, new or spreading foot ulcers, signs of infection (fever, redness, pus, bad smell), sudden severe pain that does not settle, or falls with head injury. These can signal complications such as severe infection, fracture, or another overlapping problem and need quick treatment. ScienceDirect+3Mayo Clinic+3Cleveland Clinic+3
What to eat and what to avoid
1. Eat a balanced, Mediterranean-style diet – Plenty of vegetables, fruits, whole grains, legumes, nuts, seeds, and olive oil supports general and nerve health. PMC+2Frontiers+2
2. Include lean protein – Fish, poultry, eggs, tofu, and beans provide amino acids needed for muscle repair and immune function. Oily fish also supply omega-3 fats. PMC+2Frontiers+2
3. Ensure adequate B12 and other B vitamins – Eat foods rich in B12 (meat, fish, eggs, dairy) or use fortified foods/supplements if you are vegetarian or have absorption problems. Cleveland Clinic+2PubMed+2
4. Choose foods with healthy fats – Nuts, seeds, avocados, and oily fish provide fats that support cell membranes and may protect nerves from inflammation. PMC+2Frontiers+2
5. Limit sugary drinks and ultra-processed snacks – Very high sugar intake and highly processed foods can worsen metabolic health, weight gain, and inflammation, which may indirectly harm nerves. nhs.uk+2Cochrane+2
6. Avoid excessive alcohol – Heavy drinking is a well-known cause of neuropathy and can worsen existing nerve damage, so keep intake within medical guidelines or avoid it entirely. nhs.uk+2PMC+2
7. Stay well hydrated – Drinking enough water supports circulation, kidney function, and medication safety, and can ease constipation from some pain medicines. nhs.uk+2Mayo Clinic+2
8. Avoid fad extreme diets – Very low-calorie or unbalanced diets may cause vitamin and mineral deficiencies that worsen neuropathy; any major diet change should be discussed with a doctor or dietitian. nhs.uk+2Cleveland Clinic+2
9. Consider supervised use of specific supplements – If your doctor agrees, targeted supplements such as ALA, ALC, or B-vitamins may be tried, but they must not replace standard medical care. nhs.uk+3PMC+3PMC+3
10. Food safety with reduced sensation – Take care with hot drinks and hot food to avoid burns on numb hands or lips, and avoid walking barefoot on hot surfaces like sand or pavement. Charcot-Marie-Tooth Association+2Cleveland Clinic+2
Frequently asked questions (FAQs)
1. Is CMT2B caused by RAB7A mutation curable?
Right now, CMT2B is not curable. Available treatments focus on symptoms, preventing ulcers and infections, and preserving mobility and independence. Research into gene therapy, stem-cell-based treatments, and new drugs is ongoing, but these approaches are still experimental and not yet available as standard care. ScienceDirect+4PMC+4ScienceDirect+4
2. How is CMT2B different from other CMT types?
CMT2B is an axonal form of CMT type 2 where mutations in RAB7A lead to prominent sensory loss, ulcers, and sometimes toe amputations, while muscle weakness may be milder at first. Other CMT types affect myelin (type 1) or different genes and often show different patterns of weakness and deformity. CMT Research Foundation+3PMC+3National Organization for Rare Disorders+3
3. Does everyone with CMT2B need a wheelchair?
Not everyone, but many people need mobility aids at some stage. Some may only use braces and a cane, while others later use a wheelchair for longer distances. Early rehab, braces, and surgery can delay severe mobility loss and help people remain active longer. Mayo Clinic+3PMC+3PMC+3
4. Can exercise make the disease worse?
Properly designed exercise programs usually help, not harm. Over-exertion that causes prolonged pain or extreme fatigue should be avoided, but supervised strength and aerobic training improve function and quality of life in CMT according to clinical trials and systematic reviews. MDPI+3PMC+3PubMed+3
5. Will pain medicine stop nerve damage?
No. Pain medicines such as pregabalin, duloxetine, and tapentadol work on pain pathways but do not correct the underlying gene mutation or stop axonal degeneration. They are still important because good pain control allows better sleep, mood, and participation in therapy. FDA Access Data+4PMC+4ScienceDirect+4
6. Is stem-cell therapy for CMT2B available now?
At present, stem-cell treatments for peripheral neuropathy are at research or early-trial stages, mainly in diabetic neuropathy, and none are approved specifically for CMT2B. Some private clinics advertise stem-cell therapy, but experts warn that evidence is limited and risks and costs may be high. dvcstem.com+3PMC+3ScienceDirect+3
7. Can diet alone treat CMT2B?
No diet can cure a genetic neuropathy. However, a healthy eating pattern, correct vitamin levels (especially B12), and maintaining a healthy weight support general health, make rehabilitation easier, and may help nerves function as well as they can. Verywell Health+3Cleveland Clinic+3PubMed+3
8. Should family members be tested?
Because CMT2B is autosomal-dominant, close relatives may wish to consider genetic counselling and possibly genetic testing, especially if they have symptoms or are planning children. Counsellors explain pros and cons of testing, confidentiality, and reproductive options. ResearchGate+3National Organization for Rare Disorders+3CMT Research Foundation+3
9. Can children with CMT2B play sports?
Many children can join adapted sports such as swimming, cycling, or non-contact activities, with braces or supports as needed. Sports that involve high ankle stress or risk of falls may need modification. A paediatric neurologist and physiotherapist can help design safe activity plans. Mayo Clinic+3PubMed+3MDPI+3
10. Will surgery fix the disease?
Surgery can correct deformities like cavovarus foot and claw toes, reduce pain, and make walking easier, but it does not repair the damaged nerves or halt progression. Over time, new deformities can develop if weakness continues, so ongoing rehab and orthotic care remain important. ScienceDirect+3PubMed+3www.elsevier.com+3
11. How often should I see specialists?
Frequency depends on severity, but many people with CMT benefit from yearly neuromuscular reviews, more frequent physiotherapy, regular podiatry, and orthotic checks whenever braces or shoes no longer feel right. Sudden changes always warrant earlier review. Mayo Clinic+3PMC+3ScienceDirect+3
12. What is the long-term outlook?
CMT2B is usually slowly progressive. Many people remain able to walk, with or without aids, for decades, though some eventually need wheelchairs for distance. Life expectancy is generally near normal if ulcers, infections, and falls are well managed; serious complications usually relate to these issues rather than the neuropathy itself. Cleveland Clinic+3National Organization for Rare Disorders+3CMT Research Foundation+3
13. Can pregnancy worsen CMT2B?
Some women with CMT report increased fatigue or temporary worsening of symptoms during pregnancy, mainly due to weight gain and biomechanical stress. However, many complete pregnancy safely with good obstetric and neuromuscular care. Genetic counselling before pregnancy is recommended. PMC+2Mayo Clinic+2
14. How close are we to a gene therapy?
Gene therapy for some CMT types (such as CMT2S) has reached early clinical trials, but RAB7A-targeted therapies are still in preclinical phases. Understanding of the disease mechanism—especially endosomal trafficking and NGF signalling—has improved, which is a key step toward future targeted treatments. PLOS+5MDPI+5PMC+5
15. What is the most important thing I can do now?
For most people with CMT2B, the most powerful actions are: protect your feet every day, stay active with safe, regular exercise, use braces or aids early rather than late, attend regular specialist reviews, and seek emotional support when needed. These steps cannot change the gene, but they greatly shape day-to-day function and long-term quality of life. Cleveland Clinic+4PMC+4PMC+4
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 29, 2025.
